Pharma News

Daiichi Sankyo, Maruishi Pharma entered into agreement to commercialize remifentanil injection

  • Posted on: 1 July 2015
  • By: Shalini.Sharma

Maruishi Pharmaceutical Co., Ltd.  & Daiichi Sankyo Company, Limited, a global pharmaceutical company Collaborate to commercialize the general anaesthesia analgesic, remifentanil injection generic. Maruishi Pharmaceutical is currently applying for a manufacture and marketing license. Once Maruishi Pharmaceutical has acquired a license for the manufacturing and marketing of this drug, the plan is for Maruishi Pharmaceutical to handle its manufacture and Daiichi Sankyo to handle its marketing, while both companies will jointly conduct promotion activities.

Blood Pressure Drug may be Helpful in Cocaine & Alcohol Deaddiction

A drug helpful in treating high blood pressure is now effective in ceasing cocaine and alcohol addiction in animal models. This  new research give hopes to millions of addicts around the world.  Anti-hypertensive drugs block a particular type of ion channel, which is expressed not only in heart and blood vessels but also in certain brain cells. The researchers found that blocking these ion channels in brain cells, using a drug called isradipine, appears to reverse the rewiring that underlies memories of addiction-associated places. The research is published in the Molecular Psychiatry.

Test detects every known human virus from single drop of blood

  • Posted on: 30 June 2015
  • By: PharmaTutor News

Researchers have developed a new test that can detect every known human virus that currently or previously infected a person from a single drop of blood. The method developed by Howard Hughes Medical Institute (HHMI) researchers can test for current and past infections with any known human virus, including HIV and hepatitis C.

Rheumatoid Arthritis Drug Restores Skin Color in Vitiligo Patient

  • Posted on: 30 June 2015
  • By: Shalini.Sharma

Vitiligo is a common, psychologically devastating condition that causes skin to lose its pigmentation or color. Current treatments, such as steroid creams and light therapy, are not reliably effective in reversing the disease. A new study says, a drug used for treating rheumatoid arthritis has restored skin color in a female patient suffering from vitiligo -- a common, skin condition where portion of skin loses its pigmentation or color. The report was published in JAMA Dermatology.

Jubilant Life Sciences' receives ANDA approval for levofloxacin tablets

Jubilant Life Sciences Ltd, an integrated global pharmaceuticals and life sciences company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for levofloxacin tablets, 250mg and 500mg. It is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.

Gene Reactivation convert Colorectal Cancer Cells into Normal Tissue

  • Posted on: 29 June 2015
  • By: Shalini.Sharma

Nearly 700,000 people around the world die from colorectal cancer each year. Colorectal cancer is the second leading cause of cancer-related death in developed countries.  Anti-cancer therapies generally involve killing off tumor cells. A new study says, now the cancer cells can be turned back into normal tissue simply by reactivating a single gene.  The study is published in the Cell.

Pages